Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 218 | 0.91 |
| pathways Reactome | 3 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 8070
Sealed predictions
- AGPAT2 in dopamine neurons, braak-0.26 (p 0.502) → -0.68 (p 0.046)receipt 8078
Swarm cases
receipt 8078: AGPAT2 in dopamine neurons, braak
- power
- full sample -0.41 (p 0.087, n 18), 95% CI -0.74 to +0.07. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.46 (p 0.057, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.48 (p 0.042, n 18). not the mix.
- skeptic
- leave-one-out range -0.53 to -0.33, sign flips 0; without severely affected donors -0.41 (p 0.087, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for AGPAT2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts